Business Context and Reporting Period
Company: Globus Medical, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: January 8, 2020
Context: The filing reports preliminary unaudited sales results for the fourth quarter and fiscal year ended December 31, 2019, and includes preliminary guidance for the 2020 fiscal year.
Key Financial Metrics
The filing text does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These figures are contained within the press release furnished as Exhibit 99.1, which is referenced but not included in the provided text.
Material Changes
The filing text does not provide specific data to quantify material changes versus the prior comparable period. It only confirms that preliminary results for Q4 and the full year 2019 were issued.
Guidance, Outlook, and Management Commentary
- Guidance: The company issued preliminary guidance for certain financial measures for the 2020 fiscal year.
- Source: Detailed commentary and specific guidance figures are located in the press release dated January 8, 2020 (Exhibit 99.1).
- Risks and Contingencies: No specific risks or contingencies are detailed in the body of this 8-K filing.
Important Facts for Investor Verification
- Verify the specific preliminary sales figures for Q4 and FY 2019 in the attached press release (Exhibit 99.1).
- Review the detailed 2020 fiscal year guidance metrics referenced in the press release.
- Note that the information in this Item 2.02 is deemed "furnished" and not "filed" for purposes of Section 18 of the Exchange Act.